ArticleMolecular biology reports2026
Three-dimensional organoid culture enhances functional maturation of human pluripotent stem cell-derived hepatocytes.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman pluripotent stem cells (hPSCs) offer a promising source of hepatocytes for disease modeling and drug screening. However, hepatocytes derived in conventional two-dimensional (2D) cultures often exhibit incomplete maturation, limiting their physiological relevance. The molecular mechanisms underlying the improved differentiation observed in three-dimensional (3D) culture systems remain poorly understood.
resultsInduced PSCs (iPSCs) were differentiated into hepatic progenitors under 2D monolayer culture. At the hepatic progenitor stage, cells were either continued in 2D or re-aggregated into 3D organoids for hepatocyte maturation. Both conditions were cultured under identical experimental conditions throughout terminal differentiation for controlled comparison. At the end of differentiation, cultures were evaluated by immunostaining, gene and protein expression, functional assays, and RNA sequencing. Compared with 2D cultures, 3D hepatic organoids showed higher expression of mature hepatocyte markers (ALB, CPS1, AAT, and CYP3A4) and improved function, including increased albumin secretion, glycogen storage, and urea production. RNA sequencing identified 1,266 differentially expressed genes with upregulated genes enriched in hepatic metabolic pathways and downregulated genes associated with focal adhesion and extracellular (ECM)-receptor interaction.
conclusionsThese findings demonstrate that 3D organoid culture enhances iPSC-derived hepatocyte maturation by activating liver-specific transcriptional programs, while suppressing progenitor-associated gene signatures, supporting its use for liver disease modelling and drug metabolism studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.